Aprea Therapeutics, Inc. (APRE)

0.8742 +0.03 (+2.97%) USD  |  NASDAQ  |  Mar 04, 09:38
More

Aprea Therapeutics Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Modular Medical, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade